11.82USD+6.68%Mkt Cap: 321.33M $P/E: —1d ago
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spin…
Industry Peers
Health Information Services$32.06BUSDP/E 35.0
$13.38BUSDP/E 88.5
$9.62BUSD
$8.27BUSDP/E 37.0
$6.65BUSD
$5.65BUSD
$4.44BUSDP/E 34.6
$3.43BUSDP/E 160.1
$2.24BUSD
$2.14BUSDP/E 106.8
$1.71BUSD
$1.41BUSD
$1.17BUSD
$1.13BUSD
$1.06BUSDP/E 52.0
$874.42MUSDP/E Infinity
$845.49MUSDP/E 43.2
$672.72MUSDP/E 68.1
$637.77MUSD
$581.77MUSDP/E 27.4
$584.81MUSD
$552.27MUSDP/E 13.1
$524.39MUSD
$516.62MUSD
$494.46MUSDP/E 56.3
$460.71MUSDP/E 25.8
$446.52MUSDP/E 25.4
$393.58MUSDP/E 90.5
$368.70MUSDP/E 45.6
$230.81MUSDP/E 14.1
$224.12MUSDP/E 18.2
$217.63MUSD
$182.96MUSD
$156.35MUSDP/E 39.4
$168.48MUSD
$148.67MUSDP/E 29.6
$123.72MUSDP/E Infinity
$124.79MUSDP/E 18.5
$113.48MUSDP/E 25.4
$99.01MUSDP/E 17.9
$86.66MUSD
$65.63MUSDP/E 11.3
$62.29MUSDP/E 22.6
$57.34MUSD
$47.87MUSDP/E 57.6
$49.50MUSD
$40.55MUSDP/E 38.7
$39.14MUSD
$31.93MUSD
$26.93MUSDP/E 26.0
$22.91MUSDP/E 54.8
$20.17MUSD
$18.43MUSD
$12.99MUSD
$13.69MUSD
$12.35MUSD
$11.72MUSD
$9.78MUSDP/E 15.1
$6.67MUSD
$6.50MUSD
$5.63MUSD
$4.88MUSD
$3.78MUSDP/E Infinity
$3.83MUSDP/E 0.0
$3.40MUSD
$2.98MUSD
$2.70MUSD
$2.16MUSDP/E Infinity
$693.4KUSD
$548.9KUSDP/E 0.0
$282.6KUSD
—
EYES
Corgi Data & Surveillance ETF—P/E 30.8
CRY
GraniteShares YieldBOOST CRCL ETF—
—
—
Indicators:|
Key Statistics
Company
Market Cap321.33M $
Enterprise Value241.56M $
Revenue (TTM)56.44M $
Gross Profit38.04M $
Net Income (TTM)-29.63M $
Revenue/Share2.842 USD
Last Price11.82 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees127
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-8.24
PEG—
EV/EBITDA-7.15
EV/Revenue4.28
P/S5.69
P/B3.48
EPS (TTM)-0.98
EPS (Forward)-1.44
52W Range
8.50038% of range17.19
52W High17.19 USD
52W Low8.500 USD
Profitability
Gross Margin75.31%
Oper. Margin-57.56%
EBITDA Margin-59.87%
Profit Margin-58.67%
ROE-29.97%
ROA-22.77%
Growth
Revenue Growth58.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-28.98M $
CapEx (TTM)1.36M $
FCF Margin-46.78%
FCF Yield-8.22%
Net Debt-79.76M $
Net Debt/EBITDA2.36
Balance Sheet
Debt/Equity0.18
Current Ratio11.88
Quick Ratio11.25
Book Value/Sh3.394 USD
Cash/Share3.569 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)18.60 USD
Upside (mean)+57.4%
Target Range17.00 USD – 23.00 USD
$17.00+57.4% to mean$23.00
# Analysts5
Ownership
Shares Out.27.18M
Float15.55M
Insiders43.73%
Institutions40.52%
Short Interest
Short Ratio10.5d
Short % Float12.99%
Short % Out.4.83%
Shares Short1.31M
Short (prev mo.)1.31M
Technical
SMA 5011.02 (+7.3%)
SMA 20012.00 (-1.5%)
Beta—
S&P 52W Chg20.25%
Avg Vol (30d)149.45K
Avg Vol (10d)210.48K
Technical Indicators
RSI (14)53.5
MACD0.1880
MACD Signal0.2202
MACD Hist.-0.0322
BB Upper12.94 USD
BB Middle11.31 USD
BB Lower9.669 USD
BB Width28.96%
ATR (14)0.9413 USD
Vol Ratio (20d)0.72x